Where is Janux Therapeutics (JANX) Headed According to Analysts?

2 days ago 3

Noor Ul Ain Rehman

Thu, February 19, 2026 astatine 8:59 AM CST 2 min read

Janux Therapeutics, Inc. (NASDAQ:JANX) is 1 of the champion immunotherapy stocks to bargain according to hedge funds. JonesTrading maintained a Buy standing connected Janux Therapeutics, Inc. (NASDAQ:JANX) connected January 23, mounting a terms people of $50.00. The standing update came aft Janux Therapeutics, Inc. (NASDAQ:JANX) announced connected January 22 a collaboration and exclusive worldwide licence statement with Bristol Myers Squibb, nether which the 2 companies would make an undisclosed, novel, tumor-activated therapeutic targeting a validated coagulated tumor antigen expressed crossed respective quality crab types.

Among Unknown Billionaire Phill Gross’ Stock Picks with Huge Upside Potential

David Campbell, Ph.D., President and CEO of Janux Therapeutics, Inc. (NASDAQ:JANX), stated that the collaboration marks a notable milestone for the institution and validates the spot of its tumor-activated platforms portion expanding its scope successful coagulated tumor oncology. The presumption of the statement entail that the completion of the preclinical improvement up to IND submission would beryllium undertaken by Janux Therapeutics, Inc. (NASDAQ:JANX), portion Bristol Myers Squibb volition clasp the IND and beryllium progressive with the consequent improvement and planetary commercialization. Janux Therapeutics, Inc. (NASDAQ:JANX) would stay actively progressive successful the process, supporting Bristol Myers Squibb done completion of the archetypal Phase 1 objective study.

Janux Therapeutics, Inc. (NASDAQ:JANX) is simply a preclinical signifier biopharmaceutical institution that develops therapeutics based connected the Tumor Activated T Cell Engager level technology. The institution develops tumor-activated immunotherapies for crab done 2 bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr).

While we admit the imaginable of JANX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.

Read Entire Article